论文部分内容阅读
目的观察倍他乐克治疗慢性心力衰竭的临床疗效。方法将64例慢性心力衰竭患者随机分为倍他乐克组和对照组,每组32例,两组同时应用强心剂、利尿剂及ACEI类药物,治疗组加用倍他乐克口服,1年后观察心功能的改善情况。结果倍他乐克组心功能改善总有效率明显高于对照组(P<0.05),差异有统计学意义。结论倍他乐克治疗慢性心力衰竭临床疗效好,安全方便。
Objective To observe the clinical efficacy of metoprolol in the treatment of chronic heart failure. Methods Sixty-four patients with chronic heart failure were randomly divided into metoprolol and control group, with 32 cases in each group. The two groups were treated with cardiotonic agents, diuretic agents and ACEI drugs at the same time. The patients in the treatment group were treated with Betaloc orally for 1 year After observing the improvement of cardiac function. Results The total effective rate of improving heart function in metoprolol group was significantly higher than that in control group (P <0.05), the difference was statistically significant. Conclusion Betaloc can treat chronic heart failure with good curative effect and safety and convenience.